The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +354.55% increase from the last price of 1.10.
The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.20
Reporting Date May 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.